Lars Östman Vasko

Publications

2025

David M. Howard, Lachlan Gilchrist, Petroula Proitsi, Elisabeth Paul, Markus Heilig, Lars Östman, Robin Kämpe, J. Paul Hamilton (2025) Immune and metabolic disturbance as a function of genetic risk and phase of illness in major depression Brain, Behavior, and Immunity - Health, Vol. 50, Article 101144 (Article in journal) Continue to DOI

Abigail R. Lunge, Lars Östman Vasko, Ryann Tansey, Daniel J. O. Roche, Elisabeth Paul, Andrea Johansson Capusan, Markus Heilig, Leah Mayo (2025) Individual and additive effects of childhood maltreatment and substance use disorder histories on baseline and stress-induced changes in peripheral stress biomarkers Psychopharmacology (Article in journal) Continue to DOI

Leah Mayo, Emelie Gauffin, Gavin N. Petrie, Ryann Tansey, Raegan Mary Rose Mazurka, Connor James Haggarty, Madeleine Jones, Hilda Engelbrektsson, Victoria Aminoff, Anisja Huhne-Landgraf, Mark E. Schmidt, Darrel J. Pemberton, Cecilia Fredlund, Lars Östman Vasko, Hanna Karlsson, Andreas Löfberg, Michal Pietrzak, Gerhard Andersson, Andrea Johansson Capusan, Matthew N. Hill, Markus Heilig (2025) The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet-delivered cognitive behavioral therapy in the treatment of post-traumatic stress disorder: a randomized, placebo-controlled clinical trial Neuropsychopharmacology, Vol. 50, p. 1564-1572 (Article in journal) Continue to DOI

2024

Robin Kämpe, Elisabeth Paul, Lars Östman, Markus Heilig, David M. Howard, J. Paul Hamilton (2024) Contributions of Polygenic Risk and Disease Status to Gray Matter Abnormalities in Major Depression Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, Vol. 9, p. 437-446 (Article in journal) Continue to DOI

Reinoud Kaldewaij, Paula Salamone, Adam Enmalm, Lars Östman Vasko, Michal Pietrzak, Hanna Karlsson, Andreas Löfberg, Emelie Gauffin, Martin Samuelsson, Sarah Gustavson, Andrea Johansson Capusan, Håkan Olausson, Markus Heilig, Rebecca Böhme (2024) Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study Neuropsychopharmacology, Vol. 49, p. 1767-1774 (Article in journal) Continue to DOI